MATTHEW GUGLIOTTI: Open Payments
NPI 1144456476 · NEW MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 50 payments from 20 companies in 2025. Trend: 2023 $1,107 · 2024 $805 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $211 |
| Novo Nordisk Inc | 6 | $101 |
| ABBVIE INC. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Braeburn Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
Products named: NURTEC ODT, Ozempic, BRIXADI, Auvelity, UBRELVY, REXULTI, CAPLYTA, Wegovy.
Industry payments across OH — which companies pay providers there.
